Skip to content

CytoSorb adsorption for reducing risk of bleeding during cardiac surgery in Ticagrelor/Rivaroxaban

CytoSorb adsorption for reducing risk of bleeding during cardiac surgery in Ticagrelor/Rivaroxaban treated patients
Chairs: Dr. Nandor Marczin, London/UK and Stefan Baudis, CytoSorbents Europe GmbH, Berlin/Germany

NICE Medtech Innovation Briefing review
Dr. Nandor Marczin, Senior lecturer, consultant cardiothoracic anaesthetist Imperial College London; Brompton Harefield NHS Trust, UK

How bleeding complications and costs can be reduced
Dr. Stephan Geidel, Asklepios Hospital St. George, Hamburg/Germany

Play Video

Share

|

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

CytoSorb adsorption for reducing risk of bleeding during cardiac surgery in Ticagrelor/Rivaroxaban

Play Video

Share

|

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

CytoSorb adsorption for reducing risk of bleeding during cardiac surgery in Ticagrelor/Rivaroxaban treated patients
Chairs: Dr. Nandor Marczin, London/UK and Stefan Baudis, CytoSorbents Europe GmbH, Berlin/Germany

NICE Medtech Innovation Briefing review
Dr. Nandor Marczin, Senior lecturer, consultant cardiothoracic anaesthetist Imperial College London; Brompton Harefield NHS Trust, UK

How bleeding complications and costs can be reduced
Dr. Stephan Geidel, Asklepios Hospital St. George, Hamburg/Germany

More Videos

Webinar | EuroELSO 2020 Virtual ECMO Day | June 25, 2020
Webinar | EuroELSO 2020 Virtual ECMO Day | June 25, 2020
Webinar | The trinity of COVID-19: Immunity, Inflammation and Intervention | May 20th 2020
Webinar | The trinity of COVID-19: Immunity, Inflammation and Intervention | May 20th 2020
Webinar | Cytokine adsorption in severely ill COVID-19 patients | April 16th 2020
Webinar | Cytokine adsorption in severely ill COVID-19 patients | April 16th 2020
Webinar | CytoSorb therapy in COVID-19 patients
Webinar | CytoSorb therapy in COVID-19 patients